Zobrazeno 1 - 10
of 144
pro vyhledávání: '"TM Robinson"'
Autor:
MC Ozelo, J Mahlangu, B Madan, J Mason, F Peyvandi, AV Drygalski, G Yamaguti-Hayakawa, TM Robinson, SW Pipe, TT Gener-Eigh
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S451-S452 (2023)
Aims: Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) provides endogenous factor VIII (FVIII) production to prevent bleeding in people with severe hemophilia A. This study evaluated bleeding, FVIII activity and safety outcomes 3 years after receiving val
Externí odkaz:
https://doaj.org/article/073f51b8f2be4bc78410d269a66d55b0
Autor:
Jia-Min Zhuo, Hua-an Tseng, Mitul Desai, Mark E Bucklin, Ali I Mohammed, Nick TM Robinson, Edward S Boyden, Lara M Rangel, Alan P Jasanoff, Howard J Gritton, Xue Han
Publikováno v:
eLife, Vol 5 (2016)
Adult neurogenesis supports performance in many hippocampal dependent tasks. Considering the small number of adult-born neurons generated at any given time, it is surprising that this sparse population of cells can substantially influence behavior. R
Externí odkaz:
https://doaj.org/article/a9e9f6bd6c304c46813187f7d01d71d0
Autor:
TM Robinson
Publikováno v:
Fashion Theory. 23:441-458
This article makes a case for increased dialogue between the visual-, sensory-, and material-based methods currently available within social research and modes of socio-cultural enquiry typ...
Autor:
M Titmarsh, TM Robinson
Publikováno v:
Australasian Journal of Popular Culture. 1:383-388
Publikováno v:
Journal of the American Animal Hospital Association. 34:295-299
A case of a malignant mesenchymoma with an unusual, vasoinvasive, metastatic behavior in a three-year-old, intact female basset hound is presented. Malignant mesenchymomas are rare neoplasms in humans and in dogs. No previous reports of a malignant m
Publikováno v:
Journal of the American Animal Hospital Association. 35(2)
Postoperative analgesia provided by transdermal fentanyl was compared with that provided by epidural morphine in dogs undergoing major orthopedic surgery. Dogs randomly were assigned to receive either a 100 microg per hour transdermal fentanyl patch
Autor:
Yang Y; Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA., Badura ML; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., O'Leary PC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Delavan HM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Robinson TM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., Egusa EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., Zhong X; Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA., Swinderman JT; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., Li H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., Zhang M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA., Kim M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Ashworth A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Feng FY; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, CA, USA.; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Chou J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. jonathan.chou@ucsf.edu.; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. jonathan.chou@ucsf.edu., Yang L; Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA. lixingyang@uchicago.edu.; Department of Human Genetics, University of Chicago, Chicago, IL, USA. lixingyang@uchicago.edu.; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. lixingyang@uchicago.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.
Autor:
Chou J; University of California, San Francisco, San Francisco, CA, United States., Robinson TM; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Egusa EA; University of California, San Francisco, San Francisco, CA, United States., Lodha R; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States., Zhang M; University of California, San Francisco, San Francisco, United States., Badura M; University of California, San Francisco, San Francisco, CA, United States., Mikayelyan M; University of California, San Francisco, San Francisco, CA, United States., Delavan H; University of California, San Francisco, San Francisco, CA, United States., Swinderman J; University of California, San Francisco, San Francisco, CA, United States., Wilson C; University of California, San Francisco, San Francisco, ca, United States., Zhu J; University of California, San Francisco, San Francisco, CA, United States., Das R; University Hospitals of Cleveland, Cleveland, OH, United States., Nguyen M; Clovis Oncology, Inc., San Francisco, CA, United States., Loehr A; Clovis Oncology (United States), Boulder, United States., Golsorkhi T; Clovis Oncology (United States), San Francisco, California, United States., Simmons A; Clovis Oncology, Inc., San Francisco, CA, United States., Abida W; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chinnaiyan AM; University of Michigan-Ann Arbor, Ann Arbor, MI, United States., Arkin MR; University of California, San Francisco, San Francisco, ca, United States., Small EJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States., Quigley DA; University of California, San Francisco, San Francisco, CA, United States., Yang L; University of Chicago, United States., Kim M; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States., Ashworth A; University of California, San Francisco, San Francisco, CA, United States., Feng FY; University of California, San Francisco, San Francisco, CA, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Agarwal S; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Sandza K; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Obrochta Moss K; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Vora M; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Bowen A; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Bunch B; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Holcomb J; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Robinson TM; Late Clinical Development, BioMarin Pharmaceutical Inc, Novato, CA., Jayaram K; Pharmacovigilance, BioMarin Pharmaceutical Inc, Novato, CA., Russell CB; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Zoog S; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Vettermann C; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA., Henshaw J; Translational Sciences, BioMarin Pharmaceutical Inc, Novato, CA.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4606-4615.
Autor:
Santos M; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Michael PL; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Mitchell TC; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Lam YT; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Robinson TM; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Moore MJ; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Tan RP; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Rnjak-Kovacina J; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, 2006, Australia., Lim KS; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Wise SG; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia.
Publikováno v:
Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Sep; Vol. 36 (38), pp. e2311313. Date of Electronic Publication: 2024 Mar 20.